Molina Healthcare Stock Fair Value – UBS Group Raises Molina Healthcare Price Target to $380.00
December 24, 2023
🌥️Trending News
Molina Healthcare ($NYSE:MOH), Inc. is an American health care services company based in Long Beach, California. They specialize in providing Medicaid-related solutions to state governments and their beneficiaries. Recently, analysts at UBS Group have raised the price target for Molina Healthcare to $380.00. UBS Group is a leading global financial services company, and their new price target of $380.00 is a significant increase from previous estimates. This news is seen as a positive move for Molina Healthcare, as their stock prices have been steadily increasing in recent weeks.
The raised price target indicates that UBS expects Molina Healthcare to perform well in the future, which is a great sign for investors. Molina Healthcare’s stock has been on an upward trajectory since the beginning of this year, and this raised price target from UBS will only help to further bolster investor confidence in the company. With a strong financial backdrop and optimistic outlook from UBS, Molina Healthcare appears to be well positioned to succeed in the future.
Share Price
Despite the increase in the price target, the stock was down nearly 1%. It will be interesting to see how Molina Healthcare reacts to this new price target in the coming days. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Molina Healthcare. More…
| Total Revenues | Net Income | Net Margin |
| 33.25k | 931 | 3.3% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Molina Healthcare. More…
| Operations | Investing | Financing |
| 2.14k | -571 | -244 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Molina Healthcare. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 14.87k | 10.99k | 66.54 |
Key Ratios Snapshot
Some of the financial key ratios for Molina Healthcare are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 21.7% | 8.3% | 4.1% |
| FCF Margin | ROE | ROA |
| 6.1% | 22.7% | 5.7% |
Analysis – Molina Healthcare Stock Fair Value
At GoodWhale, we conducted an analysis of MOLINA HEALTHCARE‘s wellbeing. After taking into account a variety of factors, our proprietary Valuation Line indicated that the fair value of MOLINA HEALTHCARE stock is around $336.2. However, the stock is currently being traded at a price of $358.4, suggesting that it is being overvalued by 6.6%. We believe that this could be an opportunity for investors to capitalize on the difference between the fair value of the stock and its current market price. More…
Peers
Its competitors include Centene Corp, Humana Inc, Anthem Inc.
– Centene Corp ($NYSE:CNC)
Centene Corporation is a health services company that provides access to quality, affordable health care for low-income individuals and families. It operates through three segments: Medicaid, Medicare, and Commercial. The Medicaid segment provides Medicaid services to eligible low-income individuals and families through government-sponsored programs. The Medicare segment provides Medicare Advantage, Part D prescription drug, and supplemental health benefits to Medicare-eligible individuals. The Commercial segment provides health insurance to individuals and families through the Health Care Exchanges and the individual market.
– Humana Inc ($NYSE:HUM)
Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky. As of 2019, Humana ranked #4 in largest health insurers in the United States by revenue. founded in 1961, the company has about 50,000 employees as of 2016.
The company’s market cap is $64.61 billion as of 2022, and its return on equity is 17.4%. Humana provides health insurance coverage to over 13 million people in the United States, as well as pharmacy benefits management and other health services. The company serves customers through a network of over 60,000 physicians and 5,400 hospitals.
Summary
Investment analysts at UBS Group have increased their price target on Molina Healthcare to $380.00, showing increased confidence in the company’s potential. Molina Healthcare provides government-funded healthcare plans for those eligible, including Medicaid, Medicare, and individual and family health plans. Analysts have noted the increase in demand for these services due to the pandemic, and the company has also seen an increase in profits over the past year.
Molina has been focusing on streamlining their processes and improving customer service, while also expanding their services and presence in new markets. UBS Group believe these improvements will help Molina continue to grow in the coming years, as it remains well-positioned to maximize its potential in the healthcare services industry.
